tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christopher James, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).
Analyst Christopher James, carries an average stock price target met ratio of 60% that have a potential upside of 47.66% achieved within 316 days. Previously, Christopher James worked at LADENBURG, B. RILEY.
Christopher James’s has documented 29 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ACHN, Achillion Pharmaceuticals at 12-Sep-2017.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) at 7/18/2017. The price target of $20 was fulfilled within 79 days with a profit of $7.59 (61.16%) receiving and performance score of 7.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2
$1.82 (1011.11%)
$5
5 years 11 months 26 days ago
(03-May-2019)
2/3 (66.67%)
$-0.96 (-32.43%)
528
Hold
$4
7 years 2 months 21 days ago
(08-Feb-2018)
4/4 (100%)
$-0.81 (-16.84%)
106
Buy
$5
$4.82 (2677.78%)
$6
7 years 4 months 18 days ago
(11-Dec-2017)
0/4 (0%)
$2.14 (74.83%)
Buy
$10
7 years 7 months 17 days ago
(12-Sep-2017)
0/2 (0%)
$5.79 (137.53%)
Hold
$4
$3.82 (2122.22%)
$5
7 years 7 months 18 days ago
(11-Sep-2017)
6/7 (85.71%)
$0.17 (4.44%)
49
What Year was the first public recommendation made by Christopher James?
